BETH SWENEY: Open Payments
NPI 1689136434 · ADA, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$202,608 in 415 payments from 20 companies in 2025. Trend: 2023 $145,035 · 2024 $142,823 · 2025 $202,608
Speaker / faculty: $114,515Travel & lodging: $66,952Consulting: $12,264Food & beverage: $8,659Education: $218
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 237 | $168,685 |
| UCB, Inc. | 51 | $26,877 |
| Incyte Corporation | 23 | $4,631 |
| GENZYME CORPORATION | 11 | $360 |
| Regeneron Healthcare Solutions, Inc. | 13 | $317 |
| Novartis Pharmaceuticals Corporation | 6 | $242 |
| Galderma Laboratories, L.P. | 17 | $232 |
| Arcutis Biotherapeutics, Inc. | 8 | $200 |
| LEO Pharma Inc. | 8 | $167 |
| Janssen Biotech, Inc. | 10 | $157 |
Products named: RINVOQ, SKYRIZI, DUPIXENT, Bimzelx, OPZELURA, NEMLUVIO, COSENTYX, Zoryve.
Industry payments across MI — which companies pay providers there.
